TSHA Competitors & Alternatives
Compare Taysha Gene Therapies Inc with similar stocks in the same industry
Biotechnology
TSHA
Main Stock$4.28
Tradestie Score
46
Market Cap
$867.49M
Revenue Growth
1.7%
Analyst Upside
+203.7%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.21
|
$1.50B | 7.1 | 51 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$20.95
|
$1.50B | - | 50 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$31.80
|
$1.49B | - | 43 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$18.80
|
$1.43B | - | 63 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$12.39
|
$1.42B | - | 51 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.59
|
$1.35B | - | 60 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$27.02
|
$1.32B | - | 45 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.52
|
$1.29B | - | 39 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$27.76
|
$1.29B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.13
|
$1.29B | - | 65 | Compare |
More TSHA Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
218 stocks in this industry